It is time to stop ignoring heart rate as a cardiovascular risk factor;La frequenza cardiaca: Un fattore di rischio cardiovascolare che non può essere ignorato

Giornale Italiano di Cardiologia

Volumn 7, Issue 2, 2006, Pages 119-128

  Palatini, Paolo ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Heart rate; Risk factors; Tachycardia; Therapy

Indexed keywords

AMIODARONE; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; ANTIARRHYTHMIC AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARDIOVASCULAR AGENT;

ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; DISEASE ASSOCIATION; HEART FAILURE; HEART RATE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MORBIDITY; MORTALITY; NONHUMAN; PATHOGENESIS; SEX DIFFERENCE; TACHYCARDIA; CORONARY ARTERY ATHEROSCLEROSIS; DRUG COMBINATION; DRUG EFFECT; HEART DISEASE; PATHOPHYSIOLOGY; REVIEW; RISK FACTOR; SURVIVAL RATE;

ADRENERGIC BETA-ANTAGONISTS; ANTI-ARRHYTHMIA AGENTS; ANTIHYPERTENSIVE AGENTS; CALCIUM CHANNEL BLOCKERS; CARDIOVASCULAR AGENTS; CLINICAL TRIALS; CORONARY ARTERIOSCLEROSIS; DRUG THERAPY, COMBINATION; HEART DISEASES; HEART RATE; HUMANS; HYPERTENSION; RISK FACTORS; SURVIVAL RATE; TACHYCARDIA;

EID: 33645637026     PISSN: 18276806     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (89)

1. Schroll M, Hagerup LM. Risk factors of myocardial infarction and death in men aged 50 at entry. A ten-year prospective study from the Glostrup population studies. Dan Med Bull 1977; 24: 252-5.
2. Levy RL, White PD, Stroud WD, Hillman CC. Transient tachycardia: prognostic significance alone and in association with transient hypertension. JAMA 1945; 129: 585-8.
3. Medalie JH, Kahn HA, Neufeld HN, Riss E, Goldbourt U. Five-year myocardial infarction incidence. II: Association of single variables to age and birthplace. J Chronic Dis 1973; 26: 325-49.
4. Kannel WB, Sorlie P. Hypertension in Framingham. In: Paul O, ed. Epidemiology and control of hypertension. New York, NY: Stratton, 1975: 553-92.
5. Thomas CB, Ross DC, Higinbothom CQ. Precursors of hypertension and coronary disease among healthy medical students: discriminant function analysis. II: Using parental history as the criterion. Bull Johns Hopkins Hosp 1964; 115: 245-64.
6. Kahn HA, Medalie JH, Neufeld HN, Riss E, Goldbourt U. The incidence of hypertension and associated factors: the Israel ischemic heart disease study. Am Heart J 1972; 84: 171-82.
7. Dyer AR, Persky V, Stamler J, et al. Heart rate as a prognostic factor for coronary heart disease and mortality: findings in three Chicago epidemiologic studies. Am J Epidemiol 1980; 112: 736-49.
8. Gillum RF, Makuc DM, Feldman JJ. Pulse rate, coronary heart disease, and death: the NHANES I epidemiologic follow-up study. Am Heart J 1991; 121 (Pt 1): 172-7.
9. Kannel WB, Wilson P, Blair SN. Epidemiological assessment of the role of physical activity and fitness in development of cardiovascular disease. Am Heart J 1985; 109: 876-85.
10. Kannel WB, Kannel C, Paffenbarger RS Jr, Cupples LA. Heart rate and cardiovascular mortality: the Framingham Study. Am Heart J 1987; 113: 1489-94.
11. Beere PA, Glagov S, Zarins CK. Retarding effect of lowered heart rate on coronary atherosclerosis. Science 1984; 226: 180-2.
12. Kaplan JR, Manuck SB, Clarkson TB. The influence of heart rate on coronary artery atherosclerosis. J Cardiovasc Pharmacol 1987; 10 (Suppl 2): S100-S102.
13. Kaplan JR, Manuck SB, Adams MR, Weingand KW, Clarkson TB. Inhibition of coronary atherosclerosis by propranolol in behaviorally predisposed monkeys fed an atherogenic diet. Circulation 1987; 76: 1364-72.
14. Sutton-Tyrrell K, Alcorn HG, Herzog H, Kelsey SF, Kuller LH. Morbidity, mortality, and antihypertensive treatment effects by extent of atherosclerosis in older adults with isolated systolic hypertension. Stroke 1995; 26: 1319-24.
15. Gordon D, Guyton JR, Karnovsky MJ. Intimal alterations in rat aorta induced by stressful stimuli. Lab Invest 1981; 45: 14-27.
16. European Society of Hypertension-European Society of Cardiology Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003; 21: 1011-53.
17. Palatini P, Julius S. Heart rate and the cardiovascular risk. J Hypertens 1997; 15: 3-17.
18. Palatini P, Julius S. Association of tachycardia with morbidity and mortality: pathophysiological considerations. J Hum Hypertens 1997; 11 (Suppl 1): S19-S27.
19. Stamler J, Berkson DM, Dyer A, et al. Relationship of multiple variables to blood pressure: findings from four Chicago epidemiologic studies. In: Paul O, ed. Epidemiology and control of hypertension. Miami, FL: Symposia Specialists, 1975: 307-52.
20. Reed D, McGee D, Yano K. Biological and social correlates of blood pressure among Japanese men in Hawaii. Hypertension 1982; 4: 406-14.
21. Cirillo M, Laurenzi M, Trevisan M, Stamler J. Hematocrit, blood pressure, and hypertension. The Gubbio Population Study. Hypertension 1992; 20: 319-26.
22. ). Hypertension 1992; 20: 802-8.
23. Feskens EJ, Kromhout D. Hyperinsulinemia, risk factors, and coronary heart disease. The Zutphen Elderly Study. Arterioscler Thromb 1994; 14: 1641-7.
24. Julius S, Gudbrandsson T, Jamerson K, Tariq Shahab S, Andersson O. The hemodynamic link between insulin resistance and hypertension. J Hypertens 1991; 9: 983-6.
25. Julius S. Transition from high cardiac output to elevated vascular resistance in hypertension. Am Heart J 1988; 116 (Pt 2): 600-6.
26. Garrison RJ, Kannel WB, Stokes J 3rd, Castelli WP. Incidence and precursors of hypertension in young adults: the Framingham Offspring Study. Prev Med 1987; 16: 235-51.
27. Widimsky J, Fejfarova MH, Fejfar Z. Changes of cardiac output in hypertensive disease. Cardiologia 1957; 31: 381-9.
28. Mo R, Nordrehaug J, Omvik P, Lund-Johansen P. The Bergen Blood Pressure Study: prehypertensive changes in cardiac structure and function in offspring of hypertensive families. Blood Press 1995; 4: 16-22.
29. Kim JR, Kiefe CI, Liu K, Williams OD, Jacobs DR Jr, Oberman A. Heart rate and subsequent blood pressure in young adults: the CARDIA study. Hypertension 1999; 33: 640-6.
30. Gillmann MW Kannel WB, Belanger A, D'Agostino RB. Influence of heart rate on mortality among persons with hypertension: the Framingham Study. Am Heart J 1993; 125: 1148-54.
31. Jouven X, Desnos M, Guerot C, Ducimetiere P. Predicting sudden death in the population: the Paris Prospective Study I. Circulation 1999; 99: 1978-83.
32. Palatini P, Casiglia E, Julius S, Pessina AC. High heart rate: a risk factor for cardiovascular death in elderly men. Arch Intern Med 1999; 159: 585-92.
33. Greenland P, Daviglus ML, Dyer AR, et al. Resting heart rate is a risk factor for cardiovascular and noncardiovascular mortality: the Chicago Heart Association Detection Project in Industry. Am J Epidemiol 1999; 149: 853-62.
34. Benetos A, Rudnichi A, Thomas F, Safar M, Guize L. Influence of heart rate on mortality in a French population: role of age, gender, and blood pressure. Hypertension 1999; 33: 44-52.
35. Kristal-Boneh E, Silber H, Harari G, Froom P. The association of resting heart rate with cardiovascular, cancer and all-cause mortality. Eight year follow-up of 3527 male Israeli employees (the CORDIS Study). Eur Heart J 2000; 21: 116-24.
36. Thomas F, Bean K, Provost JC, Guize L, Benetos A. Combined effects of heart rate and pulse pressure on cardiovascular mortality according to age. J Hypertens 2001; 19: 863-9.
37. Benetos A, Thomas F, Bean K, Albaladejo P, Palatini P, Guize L. Resting heart rate in older people: a predictor of survival to age 85. J Am Geriatr Soc 2003; 51: 284-5.
38. Goldberg RJ, Larson M, Levy D. Factors associated with survival to 75 years of age in middle-aged men and women. The Framingham Study. Arch Intern Med 1996; 156: 505-9.
39. Palatini P, Thijs L, Staessen JA, et al, for the Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Predictive value of clinic and ambulatory heart rate for mortality in elderly subjects with systolic hypertension. Arch Intern Med 2002; 162: 2313-21.
40. Filipovsky J, Ducimetiere P, Safar ME. Prognostic significance of exercise blood pressure and heart rate in middle-aged men. Hypertension 1992; 20: 333-9.
41. Sandvik L, Erikssen J, Ellestad M, et al. Heart rate increase and maximal heart rate during exercise as predictors of cardiovascular mortality: a 16-year follow-up study of 1960 healthy men. Coron Artery Dis 1995; 6: 667-79.
42. Mensink GB, Hoffmeister H. The relationship between resting heart rate and all-cause, cardiovascular and cancer mortality. Eur Heart J 1997; 18: 1404-10.
43. Reunanen A, Karjalainen J, Ristola P, Heliovaara M, Knekt P, Aromaa A. Heart rate and mortality. J Intern Med 2000; 247: 231-9.
44. Fujiura Y, Adachi H, Tsuruta M, Jacobs DR Jr, Hirai Y, Imaizumi T. Heart rate and mortality in a Japanese general population: an 18-year follow-up study. J Clin Epidemiol 2001; 54: 495-500.
45. Jouven X, Zureik M, Desnos M, Guerot C, Ducimetiere P. Resting heart rate as a predictive risk factor for sudden death in middle-aged men. Cardiovasc Res 2001; 50: 373-8.
46. Menotti A, Mulder I, Nissinen A, et al. Cardiovascular risk factors and 10-year all-cause mortality in elderly European male populations; the FINE study. Finland, Italy, Netherlands, Elderly. Eur Heart J 2001; 22: 573-9.
47. Seccareccia F, Pannozzo F, Dima F, et al, for the Malattie Cardiovascolari Aterosclerotiche Istituto Superiore di Sanità Project. Heart rate as a predictor of mortality: the MATISS project. Am J Public Health 2001; 91: 1258-63.
48. Nilsson PM, Nilsson JA, Hedblad B, Berglund G. Sleep disturbance in association with elevated pulse rate for prediction of mortality - consequences of mental strain? J Intern Med 2001; 250: 521-9.
49. Chang M, Havlik RJ, Corti MC, Chaves PH, Fried LP, Guralnik JM. Relation of heart rate at rest and mortality in the Women's Health and Aging Study. Am J Cardiol 2003; 92: 1294-9.
50. Perk G, Stessman J, Ginsberg G, Bursztyn M. Sex differences in the effect of heart rate on mortality in the elderly. J Am Geriatr Soc 2003; 51: 1260-4.
51. Hozawa A, Ohkubo T, Kikuya M, et al. Prognostic value of home heart rate for cardiovascular mortality in the general population: the Ohasama study. Am J Hypertens 2004; 17 (Pt 1): 1005-10.
52. Okamura T, Hayakawa T, Kadowaki T, et al, for the NIPPONDATA80 Research Group. Resting heart rate and cause-specific death in a 16.5-year cohort study of the Japanese general population. Am Heart J 2004; 147: 1024-32.
53. Hjalmarson A, Gilpin EA, Kjekshus J, et al. Influence of heart rate on mortality after acute myocardial infarction. Am J Cardiol 1990; 65: 547-53.
54. Disegni E, Goldbourt U, Reicher-Reiss H, et al. The predictive value of admission heart rate on mortality in patients with acute myocardial infarction. SPRINT Study Group. Secondary Prevention Reinfarction Israeli Nifedipine Trial. J Clin Epidemiol 1995; 48: 1197-205.
55. Lee KL, Woodlief LH, Topol EJ, et al. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41021 patients. GUSTO-I Investigators. Circulation 1995; 91: 1659-68.
56. Copie X, Hnatkova K, Staunton A, Fei L, Camm AJ, Malik M. Predictive power of increased heart rate versus depressed left ventricular ejection fraction and heart rate variability for risk stratification after myocardial infarction. Results of a two-year follow-up study. J Am Coll Cardiol 1996; 27: 270-6.
57. Marchioli R, Avanzini F, Barzi F, et al, for the GISSI-Prevenzione Investigators. Assessment of absolute risk of death after myocardial infarction by use of multiple-risk-factor assessment equations: GISSI-Prevenzione mortality risk chart. Eur Heart J 2001; 22: 2085-103.
58. Berton GS, Cordiano R, Palmieri R, Gheno G, Mormino P, Palatini P. Heart rate during myocardial infarction: relationship with one-year global mortality in men and women. Can J Cardiol 2002; 18: 495-502.
59. Abildstrom SZ, Jensen BT, Agner E, et al, for the BEAT Study Group. Heart rate versus heart rate variability in risk prediction after myocardial infarction. J Cardiovasc Electrophysiol 2003; 14: 168-73.
60. Kovar D, Cannon CP, Bentley JH, Charlesworth A, Rogers WJ. Does initial and delayed heart rate predict mortality in patients with acute coronary syndromes? Clin Cardiol 2004; 27: 80-6.
61. Sega R, Facchetti R, Bombelli M, et al. Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study. Circulation 2005; 111: 1777-83.
62. Jouven X, Empana JP, Schwartz PJ, Desnos M, Courbon D, Ducimetiere P. Heart-rate profile during exercise as a predictor of sudden death. N Engl J Med 2005; 352: 1951-8.
63. Thomas F, Rudnichi A, Bacri AM, Bean K, Guize L, Benetos A. Cardiovascular mortality in hypertensive men according to presence of associated risk factors. Hypertension 2001; 37: 1256-61.
64. Aronow WS, Ahn C, Mercando AD, Epstein S. Association of average heart rate on 24-hour ambulatory electrocardiograms with incidence of new coronary events at 48-month follow-up in 1311 patients (mean age 81 years) with heart disease and sinus rhythm. Am J Cardiol 1996; 78: 1175-6.
65. Diaz A, Bourassa MG, Guertin MC, Tardif JC. Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease. Eur Heart J 2005; 26: 967-74.
66. Linnemann B, Janka HU. Prolonged QTc interval and elevated heart rate identify the type 2 diabetic patient at high risk for cardiovascular death. The Bremen Diabetes Study. Exp Clin Endocrinol Diabetes 2003; 111: 215-22.
67. Palatini P. Heart rate as a cardiovascular risk factor: do women differ from men? Ann Med 2001; 33: 213-21.
68. Lechat P, Hulot JS, Escolano S, et al. Heart rate and cardiac rhythm relationships with bisoprolol benefit in chronic heart failure in CIBIS II Trial. Circulation 2001; 103: 1428-33.
69. Stamler J. Epidemiology, established major risk factors and the primary prevention of coronary heart disease. In: Chatterjee K, Cheitlin MD, Karliner J, et al, eds. Cardiology: an illustrated text. Vol 2. Philadelphia, PA: Lippincott, 1991: 7.2-7.35.
70. Jamerson KA, Julius S, Gudbrandsson T, Andersson O, Brant DO. Reflex sympathetic activation induces acute insulin resistance in the human forearm. Hypertension 1993; 21: 618-23.
71. Jamerson KA, Smith SD, Amerena JV, Grant E, Julius S. Vasoconstriction with norepinephrine causes less forearm insulin resistance than a reflex sympathetic vasoconstriction. Hypertension 1994; 23 (Pt 2): 1006-11.
72. Jamerson KA, Nesbitt SD, Amerena JV, Grant E, Julius S. Angiotensin mediates forearm glucose uptake by hemodynamic rather than direct effects. Hypertension 1996; 27: 854-8.
73. Pollare T, Lithell H, Selinus I, Berne C. Application of prazosin is associated with an increase of insulin sensitivity in obese patients with hypertension. Diabetologia 1988; 31: 415-20.
74. Bassiouny HS, Zarins CK, Kadowaki MH, Glagov S. Hemodynamic stress and experimental aortoiliac atherosclerosis. J Vasc Surg 1994; 19: 426-34.
75. Julius S, Li Y, Brant D, Krause L, Buda AJ. Neurogenic pressor episodes fail to cause hypertension, but do induce cardiac hypertrophy. Hypertension 1989; 13: 422-9.
76. Lown B, Verrier RL. Neural activity and ventricular fibrillation. N Engl J Med 1976; 294: 1165-70.
77. Mangoni AA, Mircoli L, Giannattasio C, Ferrari AU, Mancia G. Heart rate-dependence of arterial distensibility in vivo. J Hypertens 1996; 14: 897-901.
78. Heidland UE, Strauer BE. Left ventricular muscle mass and elevated heart rate are associated with coronary plaque disruption. Circulation 2001; 104: 1477-82.
79. Kjekshus JK. Importance of heart rate in determining beta-blocker efficacy in acute and long-term acute myocardial infarction intervention trials. Am J Cardiol 1986; 57: 43F-49F.
80. Kjekshus JK. Comments on beta-blockers: heart rate reduction, a mechanism of action. (abstr) Eur Heart J 1985; 6 (Suppl): 29.
81. The Goteborg Metoprolol Trial in acute myocardial infarction. Am J Cardiol 1984; 53: 10D-50D.
82. The International Collaborative Study Group. Reduction of infarct size with the early use of timolol in acute myocardial infarction. N Engl J Med 1984; 310: 9-15.
83. Taylor SH, Silke B, Ebbutt A, Sutton GC, Pout GJ, Burley DM. A long-term prevention study with oxprenolol in coronary heart disease. N Engl J Med 1982; 307: 1293-301.
84. Teo KK, Yusuf S, Furberg CD. Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction: an overview of results from randomized controlled trials. JAMA 1993; 270: 1589-95.
85. Packer M, Bristow MR, Cohn JN, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. US Carvedilol Heart Failure Study Group. N Engl J Med 1996; 334: 1349-55.
86. Nul DR, Doval HC, Grancelli HO, et al. Heart rate is a marker of amiodarone mortality reduction in severe heart failure. The GESICA-GEMA Investigators. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiac en Argentina-Grupo de Estudios Multicentricos en Argentina. J Am Coll Cardiol 1997; 29: 1199-205.
87. Farinaro E, Stranges S, Guglielmucci G, et al. Heart rate as a risk factor in hypertensive individuals. The Italian TensioPulse Study. Nutr Metab Cardiovasc Dis 1999; 9: 196-202.
88. f) to generation of spontaneous activity in rabbit sino-atrial node myocytes. J Physiol 1991; 434: 23-40.
89. f current inhibition with ivabradine: a new therapeutic perspective in cardiovascular disease. Drugs 2004; 64: 1757-65.